Related Experiment Videos
Insights
New treatments like ECMO are improving survival rates for infants with congenital diaphragmatic hernia. Research into fetal surgery and other therapies offers hope for better outcomes in this challenging condition.
Area of Science:
- Pediatric Surgery
- Neonatology
- Developmental Biology
Background:
- Congenital diaphragmatic hernia (CDH) presents significant challenges in infant care.
- Understanding CDH anatomy and physiology is crucial for effective management.
- Part I of this series covered CDH incidence, embryology, diagnosis, and conventional treatment.
Purpose of the Study:
- To discuss alternative management strategies for CDH beyond conventional methods.
- To explore outcome predictors, current research, and follow-up care for infants with CDH.
- To highlight recent advancements in treating CDH.
Main Methods:
- Review of non-conventional treatment modalities for CDH.
- Analysis of outcomes associated with novel therapies.
- Discussion of ongoing research in pharmacologic therapy, fetal surgery, lobar transplant, and ventilatory management.
Main Results:
- Extracorporeal membrane oxygenation (ECMO) has demonstrated success in treating CDH.
- Infants with previously fatal risk factors are now surviving due to ECMO.
- Emerging therapies show promising results for CDH management.
Conclusions:
- Advances in non-conventional treatments, particularly ECMO, have significantly improved CDH infant survival.
- Ongoing research into fetal surgery, pharmacologic therapy, lobar transplant, and ventilatory strategies offers future hope.
- A comprehensive understanding of CDH and its evolving treatments is vital for optimizing patient care and outcomes.
Abstract:
The infant with a congenital diaphragmatic hernia presents many challenges to those caring for him. A thorough understanding of both anatomic and physiologic components can enable the caregiver to accurately assess the patient and employ interventions which will minimize complications. Part I of this article discussed the incidence, mortality, embryology, diagnosis, pathophysiology, and conventional management. This article discusses alternatives to conventional management, outcome predictors, current research and follow-up of the infant with congenital diaphragmatic hernia. Recent advances in the use of non-conventional treatment, especially ECMO, for infants with diaphragmatic hernias have proven successful. Infants having risk factors associated with 100 percent mortality prior to the advent of ECMO are now surviving. In addition to ECMO, pharmacologic therapy, fetal surgery, lobar transplant, and ventilatory management research show promising results for treatment of the infant with a congenital diaphragmatic hernia.